Juergen Eckhardt, MD, MBA
EVP, Head of Business Development & Licensing (BD&L) at Bayer, and Head of Leaps by Bayer
Dr. Juergen Eckhardt served as Metagenomi’s chairperson of the board from September 2020 to February 2024. In addition to being Head of Bayer’s Business Development & Licensing, he is Head of Bayer’s strategic investment unit, Leaps by Bayer. He has been a venture investor since 2002 and has served on more than 25 company boards.
Previously, Dr. Eckhardt was a management consultant and Associate Partner at McKinsey, where he was a member of McKinsey’s Healthcare Leadership Team. He began his career as a radiologist at the University Hospital of Basel, Switzerland. Dr. Eckhardt received his MD from the University of Basel and his MBA from INSEAD in Fontainebleau, France.